Frequently Asked Questions
The market is segmented based on Global Point of Care (PoC) Lipid Test Market, By Product (Consumables and Instruments), Application (Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Tangier Disease, Familial Hypercholesterolemia and Others), Disease Indication (Lipid and Lipoprotein Disorders, Atherosclerosis, Liver and Renal Diseases, Diabetes Mellitus, Others), Mode (OTC-Based Testing and Prescription-Based Testing), End-User (Hospitals, Clinics, Research and Diagnostic Laboratories and Others) – Industry Trends and Forecast to 2030.
.
The Global Point Of Care Poc Lipid Test Market size was valued at USD 2.86 USD Million in 2022.
The Global Point Of Care Poc Lipid Test Market is projected to grow at a CAGR of 4.84% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
